Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by princeofcuton Apr 20, 2015 9:40am

105 Views

Post# 23645766

RE:RE:RE:RE:RE:RE:RE:RE:These swings are crazy

pickupstixs, hilarious beyond belief, keep em coming..you are true entertainment..a class clown and my MB toy...luv it so you claim "stockhouse has way more power than people think" man oh man that is rubism in its purist form...is that like more power than when say RVX NR's a failed ASSURE trial and it craters say +90% and then the pumper leftcoast post his fraudster idiocy and helps the price regain 1%...is that like the way more power???? or how bout when RVX lets the market know it is going into PIII and the price recovers from its low..keep em coming pikupstix you are truly funny... ROTFLMAO

Bullboard Posts

Cybin launches new program phase to treat Major Depressive Disorder